Multifunctional Nanosystems for Precision Oncology: Real-time Monitoring and Controlled Release for Tumor-specific Treatment

Abstract

The rapid advancements in multifunctional nanosystems for precision oncology necessitate a comprehensive review to consolidate recent developments, evaluate their clinical potential, and address existing challenges. As cancer therapy shifts toward personalized approaches, integrating real-time monitoring and controlled drug release into a single platform has become critical for improving treatment efficacy and patient outcomes. This review highlights the urgent need to bridge the gap between innovative nanoplatforms and their clinical translation, emphasizing biocompatibility, scalability, and regulatory hurdles. This review provides key insights into the design and functionality of hybrid nanoparticles, nanogels, hydrogels, and magnetoliposomes, showcasing their ability to combine diagnostics and therapeutics for tumor-specific targeting. It explores stimulus-responsive mechanisms, such as pH, reactive oxygen species, and enzyme-triggered drug release, that enhance precision in oncology. Advanced real-time monitoring techniques, including fluorescence and magnetic resonance imaging (MRI)-based imaging, are examined for their role in optimizing treatment regimens. The review also discusses clinical studies demonstrating the efficacy of multifunctional nanosystems in overcoming multidrug resistance and improving therapeutic outcomes. Challenges such as biocompatibility, large-scale production, and regulatory barriers are critically analyzed to identify roadblocks in clinical adoption. Furthermore, the integration of nanosystems with immunotherapy and multimodal therapies is highlighted as a promising strategy for synergistic cancer treatment. Future research should focus on refining targeting strategies, improving biocompatibility, and developing standardized protocols for clinical application. The potential of organ-on-a-chip models to simulate tumor microenvironments and predict therapeutic responses warrants further exploration. Ultimately, this review underscores the transformative potential of multifunctional nanosystems in advancing precision oncology and calls for interdisciplinary efforts to accelerate their translation into clinical practice.